Concepedia

Kelvin K. H. Tong

KK

Statistics

Publications

20

Citations

571

H-Index

14

Active since

2018

Affiliations

University of Auckland(Current)

Cancer Society of New Zealand

Maurice Wilkins Centre

The University of Adelaide

City University of Hong Kong

Kelvin K. H. Tong is an author at University of Auckland specializing in ligand binding, anticancer activity, and medicinal chemistry.

ORCID

Publications per year

2018–2023

20

Publications

20

Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl<sub>2</sub>Complexes

Dianna Truong, Matthew P. Sullivan, Kelvin K. H. Tong et al. · Inorganic Chemistry · 2020 · 74 citations

, , +17

Heteroleptic Pd(II) and Pt(II) Complexes with Redox-Active Ligands: Synthesis, Structure, and Multimodal Anticancer Mechanism

N. F. Romashev, Pavel A. Abramov⧫, Ivan V. Bakaev⧫ et al. · Inorganic Chemistry · 2022 · 60 citations

, , +16

Anticancer organorhodium and -iridium complexes with low toxicity <i>in vivo</i> but high potency <i>in vitro</i>: DNA damage, reactive oxygen species formation, and haemolytic activity

Shahida Parveen, Muhammad Hanif, Euphemia Leung et al. · Chemical Communications · 2019 · 56 citations

, , +15

(Pyridin-2-yl)-NHC Organoruthenium Complexes: Antiproliferative Properties and Reactivity toward Biomolecules

Sanam Movassaghi, Sukhjit Singh, Aewan Mansur et al. · Organometallics · 2018 · 48 citations

, , +17

Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility

William D. J. Tremlett, Kelvin K. H. Tong, Tasha R. Steel et al. · Journal of Inorganic Biochemistry · 2019 · 45 citations

, , +11

1–5 of 20